Publication

Projected impact, cost-effectiveness, and budget implications of rotavirus vaccination in Mongolia

Authored by:

Lusvan M-E, Debellut F, Clark A et al.

Full Citation:

Lusvan M-E, Debellut F, Clark A et al. 2019. Projected impact, cost-effectiveness, and budget implications of rotavirus vaccination in Mongolia. Vaccine. 37(6).

View Publication

Additional key concepts from this publication:

Vaccines are among the most cost-effective health interventions available.

Key Evidence: An impact and cost-effectiveness study of rotavirus vaccination in Mongolia estimated that rotavirus vaccination, from the government perspective, would be highly cost-effective, with a cost per DALY averted of $412 for the low-cost ROTAVAC vaccine produced in India and around $1,000 for the two other available vaccines.